Efficacy and safety of Kanglaite injection combined with chemotherapy for women breast cancer: A protocol for systematic review and meta-analysis of randomized clinical trials

BACKGROUND: Breast cancer was the second cause of cancer death and approximately accounted for 30% of all newly diagnosed cancer in American women. Adjuvant chemotherapy is the preferred treatment approach for breast patients. Kanglaite injection (KI) was commonly used as adjuvant chemotherapy combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Shengli, Qu, Biao, Qiu, Xiaoxia, Li, Nannan, Wang, Xiaoli, Hao, Jiahu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5750
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183730/
https://www.ncbi.nlm.nih.gov/pubmed/34087912
http://dx.doi.org/10.1097/MD.0000000000026245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183730/
https://www.ncbi.nlm.nih.gov/pubmed/34087912
http://dx.doi.org/10.1097/MD.0000000000026245

Ejemplares similares